Relx (RELX) Equity Ratio (2016 - 2025)

On a quarterly basis, Equity Ratio fell 30.3% to 0.16 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.16, a 30.3% decrease, with the full-year FY2025 number at 0.16, down 30.3% from a year prior.

Relx (RELX) has 10 years of Equity Ratio data on record, last reported at 0.16 in Q4 2025.

  • Equity Ratio reached 0.16 in Q4 2025 per RELX's latest filing, down from 0.23 in the prior quarter.
  • Over the last five years, Equity Ratio for RELX hit a ceiling of 0.24 in Q4 2022 and a floor of 0.16 in Q4 2025.
  • A 5-year average of 0.22 and a median of 0.23 in 2023 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: surged 56.63% in 2021, then tumbled 30.3% in 2025.
  • Tracing RELX's Equity Ratio over 5 years: stood at 0.23 in 2021, then rose by 1.94% to 0.24 in 2022, then decreased by 2.79% to 0.23 in 2023, then decreased by 0.22% to 0.23 in 2024, then plummeted by 30.3% to 0.16 in 2025.
  • Business Quant data shows Equity Ratio for RELX at 0.16 in Q4 2025, 0.23 in Q4 2024, and 0.23 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Relx 81.40 Bn 81.16 Bn - 0.16
2 Rentokil Initial 79.56 Bn 78.10 Bn - 70.46
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn 0.47
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn 0.92
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn 0.45
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn 0.37
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn 0.45
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn 0.24
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn 0.42
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn 0.81

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.16
Dec 31, 2024 0.23
Dec 31, 2023 0.23
Dec 31, 2022 0.24
Dec 31, 2021 0.23
Dec 31, 2020 0.15
Dec 31, 2019 0.16
Dec 31, 2018 0.17
Dec 31, 2017 0.18
Dec 31, 2016 0.17